LORI MIZE: Open Payments
NPI 1285129197 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 58 payments from 11 companies in 2025. Trend: 2023 $1,226 · 2024 $1,421 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $440 |
| Amgen Inc. | 15 | $187 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $116 |
| Janssen Biotech, Inc. | 4 | $65 |
| PFIZER INC. | 2 | $54 |
| Organon LLC | 2 | $38 |
| UCB, Inc. | 2 | $35 |
| Genentech USA, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $29 |
| Fresenius Kabi USA, LLC | 1 | $16 |
Products named: SKYRIZI, RINVOQ, EVENITY, OFEV, TREMFYA, XELJANZ, OTEZLA, Bimzelx.
Industry payments across MS — which companies pay providers there.
